Work

Phase 3 Multi-Center Trial Evaluating the Efficacy, Safety and Tolerability of Isunakinra (EBI-005) in Subjects with Moderate to Severe Allergic Conjunctivitis

Year: 2016

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Michael H. Goldstein, Leontia Burke, Karen L. Tubridy, Karen M. Dewar, Paul J Gomes

Institution: Tufts Medical Center

Language: English

Topic: Allergic Rhinitis and Sensitization

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,850

OpenAlex ID: W2583739648

FWCI: 1.26

Cites:

Cited by: 6

Related to: 10